10 studies found for:    SCHIZOPHRENIA 11
Show Display Options
Rank Status Study
1 Recruiting Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
Conditions: Schizoaffective Disorder;   Schizophrenia
Intervention:
2 Recruiting Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Conditions: Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
Intervention: Radiation: [11-C]OMAR
3 Completed Positron Emission Tomography (PET) Study to Describe the Relationship Between Plasma Concentrations and Brain Gly-T1 Occupancy of GSK1018921 Over Time.
Condition: Schizophrenia
Intervention: Drug: GSK1018921
4 Recruiting Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: risperidone
5 Completed First Time in Human Study (FTIH) With Positron Emission Tomography (PET)
Conditions: Schizophrenia;   Healthy Volunteer
Intervention: Drug: GSK1144814
6 Completed A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
Condition: Schizophrenia
Intervention: Procedure: pet/spect scan
7 Active, not recruiting Cognitive Remediation in 22q11DS
Conditions: 22q11.2 Deletion Syndrome;   Velo-Cardio-Facial Syndrome
Interventions: Behavioral: Cognitive remediation program;   Behavioral: Small group social skills training
8 Completed PET Neuroimaging of [11C]Mirtazapine
Conditions: Mental Disorders;   Mood Disorders;   Affective Disorders;   Depressive Disorders
Intervention: Drug: Mirtazapine
9 Terminated Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome
Conditions: Velo-cardio-facial Syndrome;   Psychosis
Interventions: Drug: Metyrosine;   Drug: Placebo
10 Completed Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
Conditions: Healthy Subjects;   Cognitive Disorders
Intervention: Drug: GSK1034702

Indicates status has not been verified in more than two years